By Devika Patel
Knoxville, Tenn., July 29 - Omeros Corp. said it has secured a $40 million committed equity financing facility with Azimuth Opportunity Ltd. Reedland Capital Partners is the agent.
Azimuth has committed to purchase up to $40 million of the company's common shares over two years. The shares will be sold at a pre-negotiated discount ranging from 4% to 7%.
The biopharmaceutical company is based in Seattle.
| Issuer: | Omeros Corp.
|
| Issue: | Committed equity financing facility
|
| Amount: | $40 million
|
| Tenor: | Two years
|
| Price: | Discount of 4% to 7%
|
| Warrants: | No
|
| Agent: | Reedland Capital Partners
|
| Investor: | Azimuth Opportunity Ltd.
|
| Settlement date: | July 29
|
| Stock symbol: | Nasdaq: OMER
|
| Stock price: | $7.38 at close July 28
|
| Market capitalization: | $154.48 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
